Topical Corticosteroid in Foam Vehicle Offers Comparable Coverage Compared with Traditional Vehicles

June 2000 in “ Journal of the American Academy of Dermatology ”

Steven R. Feldman, Namrata Sangha, V. Setaluri

topical corticosteroid betamethasone valerate foam vehicle scalp dermatoses cream lotion gel solution fingertip units FTUs topical steroid betamethasone foam scalp conditions

From the encyclopedia

Betamethasone Valerate →

Betamethasone →

Studysummary This study found that betamethasone valerate in a foam vehicle has comparable total coverage to traditional topical corticosteroid vehicles, despite less coverage per unit of foam.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on jaad.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research A Review of Topical Corticosteroid Foams

3 citations , August 2019 in “PubMed”

This study found that topical corticosteroid foams are effective and generally preferred by patients for a variety of corticosteroid-responsive skin conditions, demonstrating significant clinical benefits such as improved psoriasis symptoms and hair regrowth in alopecia areata compared to traditional forms.

research Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis

9 citations , September 2019 in “Clinical Cosmetic and Investigational Dermatology”

In this article, the authors reported that calcipotriol/betamethasone dipropionate aerosol foam significantly improved scalp psoriasis symptoms in three patients by reducing itching and improving flaky patches within a four-week treatment period, confirming its efficacy and enhanced skin penetration compared to older formulations.

Efficacy of Betamethasone Valerate Foam Formulation in Comparison with Betamethasone Dipropionate Lotion in the Treatment of Mild-to-Moderate Alopecia Areata: A Multicenter, Prospective, Randomized, Controlled, Investigator-Blinded Trial

research Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial

66 citations , July 2003 in “International Journal of Dermatology”

This study found that betamethasone valerate foam was more effective and well-tolerated than betamethasone dipropionate lotion in treating mild-to-moderate alopecia areata, with higher hair regrowth rates observed.

research Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis

16 citations , December 2008 in “Journal of The American Academy of Dermatology”

This study found that adherence to topical hydrocortisone in adults with atopic dermatitis was inconsistent and not significantly different across different medication vehicles, though disease severity improved markedly within 2 weeks.

Randomized Comparison of Topical Betamethasone Valerate Foam, Intralesional Triamcinolone Acetonide, and Tacrolimus Ointment in Management of Localized Alopecia Areata

research Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata

48 citations , January 2011 in “International journal of trichology”

This study found that intralesional triamcinolone acetonide was most effective for hair regrowth in localized alopecia areata, with betamethasone valerate foam also being beneficial, while tacrolimus ointment showed no significant effect.